In this study, we used the widely characterized U87MG human GBM cell line and CD14+ human primary monocytes, or the THP-1 human leukemia monocytic cell line to evaluate the impact of soluble factors as well as cell-to-cell dependent signaling on the behavior of both the GBM cells and the monocytes. The gene discussed is CD14; the disease is glioblastoma.